Protagonist Therapeutics Inc News - PTGX | Aktien NASDAQ | ADVFN

Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX) News

Protagonist Therapeutics Inc (PTGX)

53,05

-1,30

(-2,39%)

Geschlossen 21 März 9:00PM

Verzögert um 15 Minuten

53,05

0,00

(0,00%)

Nach Börsenschluss: 12:58AM

Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Protagonist Therapeutics

Fusion Pharmaceuticals

Pure Hydrogen (PK)

BNP Paribas Issuance

Leonteq Securities

AllianzIM US Equity Buff...

Hudson Acquisition I

Ishares V Plc Msci World... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen